Signal transduction through EGFR also activates the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamicine (mTOR) signalling cascade, which is critical to cell survival, motility, and invasion, thus further promoting cancer survival and progression [8,9,10]. The gene discussed is AKT1; the disease is cancer.